Skip to Content
Merck
  • Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions.

Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions.

The Journal of cell biology (2014-09-17)
Dipal M Patel, Adi D Dubash, Geri Kreitzer, Kathleen J Green
ABSTRACT

Mechanisms by which microtubule plus ends interact with regions of cell-cell contact during tissue development and morphogenesis are not fully understood. We characterize a previously unreported interaction between the microtubule binding protein end-binding 1 (EB1) and the desmosomal protein desmoplakin (DP), and demonstrate that DP-EB1 interactions enable DP to modify microtubule organization and dynamics near sites of cell-cell contact. EB1 interacts with a region of the DP N terminus containing a hotspot for pathogenic mutations associated with arrhythmogenic cardiomyopathy (AC). We show that a subset of AC mutations, in addition to a mutation associated with skin fragility/woolly hair syndrome, impair gap junction localization and function by misregulating DP-EB1 interactions and altering microtubule dynamics. This work identifies a novel function for a desmosomal protein in regulating microtubules that affect membrane targeting of gap junction components, and elucidates a mechanism by which DP mutations may contribute to the development of cardiac and cutaneous diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-(+)-Arabinose, 99%
Sigma-Aldrich
L-(+)-Arabinose, ≥99% (GC)
Sigma-Aldrich
L-(+)-Arabinose, BioUltra, ≥99.5% (sum of enantiomers, HPLC)
Sigma-Aldrich
L-(+)-Arabinose, 98%
Sigma-Aldrich
Diphenylcyclopropenone, 98%
Sigma-Aldrich
L-(+)-Arabinose, ≥99% (GC)
Sigma-Aldrich
Vitamin B12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Anti-β-Catenin antibody produced in rabbit, whole antiserum
Sigma-Aldrich
Vitamin B12, ≥98%
Sigma-Aldrich
Vitamin B12, Vetec, reagent grade, ≥98%
Supelco
Glutathione, Pharmaceutical Secondary Standard; Certified Reference Material
Glutathione, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
MISSION® esiRNA, targeting human DSP
Cyanocobalamin, European Pharmacopoeia (EP) Reference Standard
Supelco
Cyanocobalamin, pharmaceutical secondary standard, certified reference material
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Srpr
Sigma-Aldrich
Cyanocobalamin, tested according to Ph. Eur.
Supelco
Cyanocobalamin (B12), analytical standard
Sigma-Aldrich
Isopropyl β-D-1-thiogalactopyranoside, ≥99% (TLC)
Sigma-Aldrich
IPTG, ≥99% (TLC), ≤0.1% Dioxane
Sigma-Aldrich
L-Glutathione reduced, ≥98.0%
Sigma-Aldrich
L-Glutathione reduced, BioXtra, ≥98.0%
Sigma-Aldrich
Cyanocobalamin, meets USP testing specifications
Sigma-Aldrich
L-Glutathione reduced, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Anti-Connexin 43 Antibody, CT, cytosolic, Chemicon®, from rabbit
Isopropyl β-D-thiogalactoside, Vetec, reagent grade, ≥99%
Cyanocobalamin, British Pharmacopoeia (BP) Assay Standard
SAFC
Isopropyl β-D-1-thiogalactopyranoside
Sigma-Aldrich
L-Glutathione reduced, Vetec, reagent grade, ≥98%
Amphotericin B, European Pharmacopoeia (EP) Reference Standard